{
    "2021-12-05": [
        [
            {
                "time": "2021-10-15",
                "original_text": "Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID-19 Booster",
                        "BNT162b2",
                        "Antibody",
                        "T-cell Responses"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "U.S. administers 470.3 mln doses of COVID-19 vaccines -CDC",
                "features": {
                    "keywords": [
                        "U.S.",
                        "administers",
                        "470.3 mln doses",
                        "COVID-19 vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "10 Stocks to Buy According to Michael Rothenbergâ€™s Moab Capital",
                "features": {
                    "keywords": [
                        "10 Stocks",
                        "Buy",
                        "Michael Rothenberg",
                        "Moab Capital"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Why Moderna Is the Biggest Winner From COVID Boosters So Far",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Biggest Winner",
                        "COVID Boosters"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}